Patricia Cortazar

American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes

Lee M. Ellis, David Bernstein, Emile E. Voest et al. · Journal of Clinical Oncology · 2014 · 439 citations

Medicine, Oncology, Cancer Pharmacology +5

FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

Laleh Amiri‐Kordestani, Gideon M. Blumenthal, Qiang Xu et al. · Clinical Cancer Research · 2014 · 345 citations

Medicine, Oncology, Pharmacology +17

Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer

Patricia Cortazar, Charles E. Geyer · Annals of Surgical Oncology · 2015 · 262 citations

Medicine, Oncology, Breast Oncology +9

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group

Stuart M. Lichtman, R. Donald Harvey, Marie-Anne Damiette Smit et al. · Journal of Clinical Oncology · 2017 · 175 citations

Pharmacy, Oncology, Cancer Control +9

FDA Approval Summary: Sunitinib for the Treatment of Progressive Well-Differentiated Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors

Gideon M. Blumenthal, Patricia Cortazar, Jenny J. Zhang et al. · The Oncologist · 2012 · 148 citations · Full text

Medicine, Oncology, Pharmacology +13